Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunosuppressant side effect profile does not differ between organ transplant types.

R P Winsett1, R J Stratta, R Alloway

  • 1College of Nursing, University of Tennessee Health Science Center, Memphis 38163, USA.

Clinical Transplantation
|March 21, 2002
PubMed
Summary

Immunosuppressant side effects in transplant recipients are generally not severe, impacting quality of life minimally. This study found low overall frequency and severity, with similar profiles across different organ transplant types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pancreas Transplantation: An Alarming Crisis in Confidence.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Pre-transplant predictors of one yr weight gain after kidney transplantation.

Clinical transplantation·2014
Same author

Similar results with solitary pancreas transplantation compared with simultaneous pancreas-kidney transplantation in the new millennium.

Transplantation proceedings·2014
Same author

5-year results of a prospective, randomized, single-center study of alemtuzumab compared with rabbit antithymocyte globulin induction in simultaneous kidney-pancreas transplantation.

Transplantation proceedings·2014
Same author

Program-specific reports for pancreas transplantation: comparing apples and oranges, apples after oranges and apples alone.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013

Area of Science:

  • Transplantation immunology
  • Clinical pharmacology
  • Patient-reported outcomes

Background:

  • Organ transplantation significantly improves recipient quality of life.
  • Concerns persist regarding adverse effects of immunosuppressant medications.
  • Assessing the impact of immunosuppression on patient well-being is crucial.

Purpose of the Study:

  • To evaluate the side effect profile of immunosuppressant drugs in solid organ transplant recipients.
  • To determine the impact of chronic immunosuppression on patients' quality of life.
  • To identify specific side effects and their prevalence across different organ transplant types.

Main Methods:

  • A nationwide survey of 505 solid organ transplant recipients (kidney, liver, heart, pancreas) was conducted.

Related Experiment Videos

  • A newly developed immunosuppressant side effect survey with four subscales (emotional burden, life/role responsibilities, mobility, GI distress) and a miscellaneous subscale was utilized.
  • Side effect frequency and severity were rated on a 0-4 scale, with overall scores ranging from 0-160.

    • Main Results:

    • Overall frequency (12.1 +/- 6.08), severity (10.5 +/- 6.96), and weighted scores (25.4 +/- 19.9) for immunosuppressant side effects were low.
    • Side effect profiles were generally similar across different organ types.
    • Heart recipients reported significantly less gastrointestinal distress compared to liver recipients (P<0.05).

    Conclusions:

    • Immunosuppressant-related side effects, while present, do not appear to be detrimental to the overall quality of life for most transplant recipients.
    • The impact of side effects is comparable across various solid organ transplant types.
    • Further research may explore long-term trends and specific interventions for managing side effects.